Salona Global Medical Device Corporation to Publish Management Information Circular, Updates Shareholder Vote Timeline
12 February 2021 - 12:30AM
Salona Global Medical Device Corporation (formerly Brattle Street
Investment Corp.) (the “
Company” or
“
Salona Global”) (TSXV:SGMD) today provided an
update as to the anticipated timing for filing its management
information circular (the “
Circular”) and
announced that the annual general and special shareholders’ meeting
(the
“Meeting”) will take place March 11, 2021 in
compliance with securities laws.
Included in the Circular will be information
relating to the matters to be placed before shareholders at the
Meeting, including the details of the previously announced
acquisition of South Dakota Partners Inc. (“SDP”)
(the “Transaction”), the Concurrent Financing (as
such term is defined in the December 21, 2020 news release),
information about the Company and information about SDP, and its
business, including financial statements of the Company and SDP,
and pro forma financial statements. The Circular will be available
on SEDAR at www.sedar.com on February 18, 2021. Readers of this
news release are encouraged to review the information in the
Circular and to vote at the Meeting. The Company is also in the
process of finalizing its S-1 Registration Statement for filing
with the United States Securities and Exchange Commission.
For more information please contact:
Les CrossChairman of the Board and Interim Chief
Executive OfficerTel: 1 (800) 760-6826Email:
Info@Salonaglobal.com
Additional Information
Completion of the Transaction is subject to a
number of conditions, including but not limited to, TSX Venture
Exchange acceptance and if applicable, disinterested shareholder
approval. Where applicable, the Transaction cannot close until the
required shareholder approval is obtained.
There can be no assurance that the Transaction
will be completed as proposed or at all. The certain financial data
contained herein is unaudited and may be subject to refinement or
modification during the audit process. Investors are cautioned
that, except as disclosed in the Circular prepared in connection
with the Transaction, any information released or received with
respect to the Transaction may not be accurate or complete and
should not be relied upon. Trading in the securities of the Company
should be considered highly speculative.
The TSX Venture Exchange Inc. has in no way
passed upon the merits of the proposed Transaction and has neither
approved nor disapproved the contents of this news release.
The securities referred to in this news release
have not been, nor will they be, registered under the United States
Securities Act of 1933, as amended, and may not be offered or sold
within the United States or to, or for the account or benefit of,
U.S. persons absent U.S. registration or an applicable exemption
from the U.S. registration requirements. This news release does not
constitute an offer for sale of securities for sale, nor a
solicitation for offers to buy any securities. Any public offering
of securities in the United States must be made by means of a
prospectus containing detailed information about the company and
management, as well as financial statements.
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Although the Company believes, in light of the
experience of its officers and directors, current conditions and
expected future developments and other factors that have been
considered appropriate that the expectations reflected in this
forward-looking information are reasonable, undue reliance should
not be placed on them because the Company can give no assurance
that they will prove to be correct. When used in this news release,
the words “estimate”, “project”, “belief”, “anticipate”, “intend”,
“expect”, “plan”, “predict”, “may” or “should” and the negative of
these words or such variations thereon or comparable terminology
are intended to identify forward-looking statements and
information. The forward-looking statements and information in this
news release include: the timing of the Company filing its
Circular, the timing of the Meeting and the Company’s plan to file
an S-1. Such statements and information reflect the current view of
the Company. Risks and uncertainties may cause actual results to
differ materially from those contemplated in those forward-looking
statements and information. By their nature, forward-looking
statements involve known and unknown risks, uncertainties and other
factors which may cause our actual results, performance or
achievements, or other future events, to be materially different
from any future results, performance or achievements expressed or
implied by such forward-looking statements. Such factors include,
among others, the following risks: (i) there is no assurance that
the Company will obtain all requisite approvals for the
Transaction, including the approval of shareholders and the TSX
Venture Exchange for the Transaction (which may be conditional upon
amendments to the terms of the Transaction); (ii) following
completion of the Transaction, the Company may require additional
financing from time to time in order to continue its operations and
financing may not be available when needed or on terms and
conditions acceptable to the Company; (iii) new laws or regulations
could adversely affect the Company’s business and results of
operations; and (iv) the stock markets have experienced volatility
that often has been unrelated to the performance of companies.
These fluctuations may adversely affect the price of the Company’s
securities, regardless of its operating performance. There are a
number of important factors that could cause the Company’s actual
results to differ materially from those indicated or implied by
forward-looking statements and information. Such factors include,
among others: material changes to the Company which require an
amendment to the Circular; currency fluctuations; disruptions or
changes in the credit or security markets; results of operation
activities and development of projects; project cost overruns or
unanticipated costs and expenses, and general market and industry
conditions and risks related to COVID-19 including various
recommendations, orders and measures of governmental authorities to
try to limit the pandemic, including travel restrictions, border
closures, non-essential business closures, quarantines,
self-isolations, shelters-in-place and social distancing,
disruptions to markets, economic activity, financing, supply chains
and sales channels, and a deterioration of general economic
conditions including a possible national or global recession. The
Company undertakes no obligation to comment on analyses,
expectations or statements made by third parties in respect of the
Company, its securities, or its financial or operating results (as
applicable). The Company cautions that the foregoing list of
material factors is not exhaustive. When relying on the Company’s
forward-looking statements and information to make decisions,
investors and others should carefully consider the foregoing
factors and other uncertainties and potential events. The Company
has assumed that the material factors referred to in the previous
paragraph will not cause such forward-looking statements and
information to differ materially from actual results or events.
However, the list of these factors is not exhaustive and is subject
to change and there can be no assurance that such assumptions will
reflect the actual outcome of such items or factors. The
forward-looking information contained in this press release
represents the expectations of the Company as of the date of this
press release and, accordingly, is subject to change after such
date. Readers should not place undue importance on forward-looking
information and should not rely upon this information as of any
other date. The Company does not undertake to update this
information at any particular time except as required in accordance
with applicable laws.
Salona Global Medical De... (TSXV:SGMD)
Historical Stock Chart
From Apr 2024 to May 2024
Salona Global Medical De... (TSXV:SGMD)
Historical Stock Chart
From May 2023 to May 2024